Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Aust N Z J Obstet Gynaecol ; 47(3): 213-5, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17550488

RESUMEN

We investigated the serial changes in blood protein S (PS) and related proteins in 11 normal pregnant women. The PS activity decreased significantly in the third trimester and reached minimum levels (23.3%) one hour after delivery. Although the PS activity was reduced markedly below the normal limits, all the women delivered safely. The mechanisms that cause the reduction in PS activity and the clinically dangerous conditions involving PS activity during pregnancy warrant further investigation.


Asunto(s)
Trabajo de Parto/sangre , Periodo Posparto/sangre , Tercer Trimestre del Embarazo/sangre , Embarazo/metabolismo , Proteína S/metabolismo , Estudios de Cohortes , Proteína de Unión al Complemento C4b , Femenino , Antígenos de Histocompatibilidad , Humanos , Proteína C/metabolismo
2.
Age Ageing ; 36(1): 104-6, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17158115

RESUMEN

We report on an 83-year-old Japanese woman with adult-onset Still's disease (AOSD), with marked hypercytokinemia (serum levels of ferritin (Fer) and interleukin (IL)-18 were markedly high). On seeing older patients with fever of unknown origin (FUO), particularly Asians, AOSD should be considered. Reduced doses of oral prednisolone following intravenous methylprednisolone (mPSL) therapy caused a flare-up of AOSD and led to Pneumocystis carinii (jeroveci) pneumonia. Low-dose methotrexate (MTX) therapy was administered as a steroid-sparing agent with good response. Our case suggests that in very elderly people, as in younger patients, MTX is useful for controlling AOSD with marked hypercytokinemia, and avoiding corticosteroid-induced adverse effects.


Asunto(s)
Antirreumáticos/uso terapéutico , Metotrexato/uso terapéutico , Enfermedad de Still del Adulto/tratamiento farmacológico , Anciano de 80 o más Años , Antiinflamatorios/efectos adversos , Antiinflamatorios/uso terapéutico , Citocinas/sangre , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Femenino , Humanos , Metilprednisolona/efectos adversos , Metilprednisolona/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA